GlassScriptPhysician profile
Emily Sisa
NPI 1275102873
$1,224.15
in general payments reported to CMS, 2019-2025
21 companies · $97.14 in 2025
The $97.14 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $471 · 2022: $425 · 2023: $214 · 2024: $16.58 · 2025: $97.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.92 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $158.95 | 2022-2023 | |
| Novo Nordisk INC | $140.70 | 2021-2022 | |
| Lilly USA, LLC | $99.59 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.19 | 2021-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $58.08 | 2021-2025 | Abilify Asimtufii |
| Astrazeneca Pharmaceuticals LP | $45.87 | 2021-2024 | Airsupra |
| Hologic Sales and Service, LLC | $40.00 | 2023 | Aptima, Thinprep 2000 Processor |
| Biohaven Pharmaceuticals, INC. | $35.34 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.45 | 2022 | |
| Alkermes, INC. | $26.67 | 2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $26.15 | 2023 | Ingrezza |
| Sanofi Pasteur INC. | $21.06 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.76 | 2022 | |
| Axsome Therapeutics, INC. | $19.17 | 2023 | Auvelity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $17.14 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.59 | 2022 | |
| Lucid Diagnostics INC. | $16.07 | 2022 | |
| Optinose US, INC. | $15.41 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.39 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Sisa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.